Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders



Insiders Menu
Roster
Transactions

CALIPER LIFE SCIENCES INC (CALP)

DateNameTitleTypeSecuritySharesPriceValueOwnershipReported
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionOption (Right to Buy)47k$6.40$300.8k 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionOption (Right to Buy)81k$6.02$487.6k 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionOption (Right to Buy)75k$4.09$306.8k 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionOption (Right to Buy)75k$1.30$97.5k 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionOption (Right to Buy)60k$3.42$205.2k 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionOption (Right to Buy)47k$6.57$308.8k 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionRestricted Stock Unit4.5k$0.00$0 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionRestricted Stock Unit22.2k$0.00$0 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionRestricted Stock Unit15k$0.00$0 11/07/2011
11/07/2011CREAGER STEPHEN ESr. VP and General CounselDispositionRestricted Stock Unit16k$0.00$0 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionCommon Stock423.2k$10.50$4.4M 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionOption (Right to Buy)20k$6.86$137.2k 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionOption (Right to Buy)37k$6.40$236.8k 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionOption (Right to Buy)65k$6.02$391.3k 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionOption (Right to Buy)75k$4.09$306.8k 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionOption (Right to Buy)30k$2.97$89.1k 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionOption (Right to Buy)75k$1.30$97.5k 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionOption (Right to Buy)60k$3.42$205.2k 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionOption (Right to Buy)58k$6.57$381.1k 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionRestricted Stock Unit4.5k$0.00$0 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionRestricted Stock Unit22.2k$0.00$0 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionRestricted Stock Unit15k$0.00$0 11/07/2011
11/07/2011Manyak David MExec VP, Drug Discovery SvcsDispositionRestricted Stock Unit19k$0.00$0 11/07/2011
11/07/2011Griffith Joseph H. IVVP, Finance & ControllerDispositionCommon Stock33.3k$10.50$349.5k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)47k$6.40$300.8k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)81k$6.02$487.6k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)75k$4.09$306.8k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)30k$2.97$89.1k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionCommon Stock82.2k$10.50$863.5k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)100k$7.71$771k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)50k$3.63$181.5k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)30k$3.78$113.4k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)22k$5.85$128.7k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)12k$6.25$75k 11/07/2011
11/07/2011KRUKA WILLIAM C.Sr VP Corporate DevelopmentDispositionOption (Right to Buy)75k$1.30$97.5k 11/07/2011
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy